Jeeva Trials alternatives for teams that need more than one login

Jeeva brings CTMS, EDC, eCOA, eConsent and televisits together under one login and one licence. If your study's success depends on what participants experience rather than what the operations team sees, that's where WeGuide fits. Native whitelabel iOS and Android apps under your brand, native wearable data, and engagement built for studies that run for years, connected to the EDC you already use.

Organise a demo See the full comparison

No pressure, no hard sell. A 30 minute walkthrough with a research colleague who's built platforms like yours.

Where WeGuide differs

Whitelabel participant mobile apps
Native wearable and sensor data
Engagement designed for retention

Used by leading research and medical institutes.

Why research teams look for a Jeeva Trials alternative

The short version

Jeeva Clinical Trials is built around a clear idea: "One login. One data model. One workflow layer. One enterprise license." From its base in Manassas, Virginia, it has assembled CTMS, EDC with randomisation, eSource, eCOA/ePRO, eConsent, televisits, scheduling and recruitment into a single platform aimed at emerging sponsors, CROs and academic medical centres. For an operations team tired of stitching point solutions together, that pitch lands.

See the full comparison

Why teams look elsewhere

The fit gap shows up on the participant side. Jeeva's platform grew from browser based, bring your own device access, which keeps setup simple but puts the participant in a vendor's portal rather than an app with your institution's name on it. The product pages we reviewed don't describe native wearable integrations, so protocols built on continuous sensor data need a separate device layer. And a platform designed around operational efficiency, with AI to cut manual work, is a different thing from a platform designed around keeping a participant engaged for five years.

We built WeGuide for that participant side. eScreening, eConsent, eCOA, push notifications, education content, gamification, telehealth and native Garmin, Apple Health, Health Connect and Fitbit Air data, in a whitelabel app your team configures through a no code Program Builder. WeGuide doesn't try to be your CTMS or your EDC. It connects to the systems you already run through the Integration Engine, so data managers keep their tools while participants get an app they'll actually open.

So the real question is which problem you're solving. If it's operational sprawl across CTMS, EDC and site workflows, Jeeva's unified model is designed for exactly that, and we'll tell you so. If it's participant recruitment, adherence and retention, especially in registries and longitudinal cohorts, that's the problem WeGuide was built around.

Key differences between WeGuide and Jeeva Trials

For teams whose study depends on the participant experience, here's what changes when you move to WeGuide.

Whitelabel participant mobile apps

WeGuide ships native iOS and Android apps published under your organisation's name and identity. Jeeva has long described its participant access as working from "any browser-enabled mobile device", a sensible BYOD approach that keeps setup light. The difference is ownership: with WeGuide, the participant's home screen shows your study, not a vendor portal, and that builds the trust long studies depend on. Each study can ship under your own App Store account and name, or use the existing WeGuide app if you'd rather not manage a listing.

Native wearable and sensor data

Garmin, Apple Health, Health Connect and Fitbit Air integrations are built into WeGuide, so passive data lands alongside eCOA responses without a separate device vendor. On supported Garmin models, WeGuide also collects raw accelerometer and gyroscope data at 25 Hz through the Garmin Health SDK. Jeeva's current product pages for eCOA, engagement and televisits don't describe native wearable integrations. If sensor data drives your endpoints, check device support before you commit, because adding a device vendor later means another contract, another validation and another app for participants.

Engagement designed for retention

Jeeva's engagement tools are strong on reach: SMS, email, video and social channels, with reminders and two way SMS confirmations. WeGuide adds the in app layer that keeps people coming back: push notifications, in app messaging, patient education content and gamification, all configured by your team. That's the difference between reminding a participant and engaging one, and in a study that runs for years it shows up in who is still enrolled at the end.

Compare

Full comparison: WeGuide vs Jeeva Trials

REDCap

Feature

Request a Demo

Primary use case

Participant engagement platform with eScreening, eConsent, eCOA, telehealth, wearables and registries

Unified eClinical platform: CTMS, EDC, eSource, eCOA/ePRO, eConsent, eVisits, recruitment, AI protocol intelligence

Target customer

Academic research, investigator led studies, registries, CROs, mid market sponsors, digital health programmes

Emerging sponsors, CROs and academic medical centres

Participant app

Native whitelabel iOS and Android apps under your organisation's brand, published under your own App Store account or through the existing WeGuide app

Browser based BYOD access from any browser enabled device, with no sponsor branded native app described on its site

eCOA and ePRO

Native, with a library of validated instruments

eCOA, ePRO and eDiaries with BYOD and multimedia questionnaires

eConsent

Built in, with version control, re-consent workflows and audit trail

Remote, in person or hybrid eConsent with video, comprehension quizzes and version tracking

CTMS

Not offered. Works alongside your CTMS

Native unified CTMS and study scheduler

EDC and randomisation

Not an EDC. Two way sync with REDCap and other systems through the Integration Engine

Native EDC with IWRS and eSource

Native wearable integration

Garmin, Apple Health, Health Connect and Fitbit Air, plus raw accelerometer and gyroscope data at 25 Hz on supported Garmin models

Not described on current product pages

Engagement

Push notifications, in app messaging, scheduling, patient education content, gamification

SMS, email, video, social channels, scheduled reminders, two way SMS

Telehealth

Built in televisits

Built in eVisits with two way audio and video

Not a headline feature

Clintelligence AI for protocol risk, site intelligence and enrolment forecasting. AI workflow automation

Registries and longitudinal cohorts

Core use case (FSHD Global registry, GenV birth cohort)

Supported (paternal registry case study for Special Fathers Network)

No code configuration

Program Builder and Medical Form Builder with conditional logic, configured by your team

Configurable workflows. Study setup quoted at two to four weeks

Multilingual

Built in translation management (used on the INHERIT study)

100+ languages stated in 2026 announcement

Security and compliance

ISO 27001:2022, HIPAA (BAA available), GDPR, FDA 21 CFR Part 11, TGA registered Class I medical device software

Displays GCP, FDA, HIPAA, GDPR, SOC 2 and ISO 9001 badges, and states the platform is designed to meet HIPAA, GDPR and 21 CFR Part 11

Hosting

Managed cloud hosting

AWS cloud. Listed on AWS Marketplace

Pricing

Project based, quote on request, includes hosting, support and modules

Public pricing calculator. Usage based contracts on AWS Marketplace, including a per participant per month dimension

REDCap

Top alternatives to Jeeva Trials in 2026

Here's the shortlist of platforms most teams evaluate alongside Jeeva. Some replace Jeeva's whole stack, others replace the participant side of it, so start with the problem you're actually trying to solve.

Alternative #1

Where WeGuide goes further

For teams that want the participant side of a study in one platform, here's what changes when you move to WeGuide.

Whitelabel apps under your brand

Native wearable data

Engagement beyond reminders

Information security certification

Keep the systems you already run

Registries and cohorts at scale

Configured by your own team

A named delivery contact

Built for regulated research

Every WeGuide study runs on our managed infrastructure. Your IT team doesn't patch servers, manage backups, or run disaster recovery drills.

TGA Registered

Registered Class I medical device software with the Therapeutic Goods Administration.

ISO 27001

Certified information security management covering access, audit, and incident response.

Data Hosted in Australia

Participant data is hosted in Australian data centres with sovereign data controls.

GDPR Compliant

GDPR, HIPAA, and 21 CFR Part 11 ready for multi-country and US-based studies.

Biometric Security

Participant access protected by PIN code and biometric authentication on device.

256-bit AES Encryption

All data encrypted at rest and in transit with automated backups and disaster recovery.

Where Jeeva Trials excels

Breadth under one login. CTMS, EDC with IWRS, eSource, eCOA/ePRO, eConsent, eVisits, a study scheduler, recruitment and AI protocol intelligence share one data model and one workflow layer. For a small sponsor or CRO that would otherwise buy five products, that consolidation is a genuine advantage, and it's something WeGuide, as a participant layer, doesn't attempt.

Price transparency. Jeeva publishes a pricing calculator and lists usage based pricing on AWS Marketplace. In a category where almost every vendor says "contact sales", letting a budget holder estimate costs before the first call is unusual and useful.

Protocol and site intelligence. With the May 2026 acquisition of Clintelligence AI, Jeeva added protocol risk prediction, patient to trial matching, site profiling and enrolment forecasting drawn from historical trial data. That's upstream of anything WeGuide does, and valuable at the protocol design stage.

Built for emerging sponsors and academic centres. Jeeva's funding from Virginia's innovation programmes and the NSF I-Corps programme, and its membership of the Global Genes Rare Corporate Alliance, reflect a team focused on making trials accessible to smaller organisations, including rare disease research. Jeeva was named an Aspirant in Everest Group's 2023 Decentralized Clinical Trials PEAK Matrix.

Flexible consent and visit models. eConsent works remotely over live video, in person on an iPad, or as a hybrid, with comprehension quizzes and multimedia content. Combined with built in eVisits, that covers most decentralised and hybrid visit patterns without extra vendors.

Registry and multichannel engagement experience. Jeeva has published a registry case study with the Special Fathers Network, a paternal registry with multichannel engagement, and lists rare disease, oncology, obesity and skincare among its therapeutic areas. Its engagement reach across SMS, email, video and social channels suits populations who won't install another app.

If your priority is consolidating trial operations on one affordable platform, Jeeva is a defensible choice. We'd rather tell you that honestly than sell you a participant platform when what you need is an operations platform.

WeGuide alongside Jeeva

‍

Running both on the same study is rarely the simplest answer, because Jeeva includes its own participant tools and two participant facing systems confuse participants. Where it can make sense is across a portfolio: a sponsor or CRO running trial operations on Jeeva, while a registry, cohort or long term follow up programme runs on WeGuide under the sponsor's brand, with data exchanged through our REST API and webhooks. We don't have a prebuilt Jeeva connector, so we'd scope any data flow on the discovery call.

The other pattern is sequencing. A study completes on Jeeva, then consenting participants move into a longitudinal programme on WeGuide, with the consent and data sharing arrangements agreed up front. Each platform does the job it was built for: Jeeva runs the trial operations, and WeGuide holds the long term participant relationship under your brand.

How the switch works

For teams moving their participant experience from Jeeva to WeGuide, or starting a registry or follow up programme on WeGuide, here's how onboarding typically plays out.

Discovery Call

A 30 minute conversation with one of our research delivery team. We look at your protocol, how you use Jeeva today, and which parts of the study are about operations and which are about participants. If staying on Jeeva is the better answer, we'll say that. No sales pitch.

Study Configuration

Our team works alongside yours to configure the study in WeGuide: consent flows, eCOA schedules, engagement content and wearable connections. If you're keeping an EDC or CTMS, we configure the Integration Engine at this stage, and if your study runs in several languages, translations are set up alongside the content. Typical timeline: two to four weeks.

Participant Onboarding

The whitelabel app goes live. Your coordinators invite participants, who download the app under your organisation's brand. Consent flows, reminders and education content are ready from day one, and wearable data starts syncing once a participant connects their device.

Ongoing Support

You get a named research delivery contact, not a ticketing queue. We stay involved for the life of the study.

Case studies: research teams that built around the participant

BRACE Trial (Murdoch Children's Research Institute)

Murdoch Children's Research Institute's BRACE trial was an international randomised trial testing whether the BCG vaccine could protect healthcare workers during COVID-19. It ran across several countries with thousands of participants. Vaccination and blood collection happened in person, and WeGuide carried the digital layer around those visits: consent, symptom reporting and ongoing engagement. It's the hybrid model most real studies use, with the clinic doing what only a clinic can and the participant's phone doing the rest.

GenV (Generation Victoria)

Generation Victoria (GenV) is a whole of state longitudinal birth cohort in Victoria, Australia, following roughly 124,000 people: about 50,000 children and 74,000 parents. A cohort like that runs on a participant app families keep on their phones for years, with push notifications, scheduling and education content doing the work no coordinator team could do by phone.

FSHD Global

FSHD Global runs a longitudinal patient registry for facioscapulohumeral muscular dystrophy on WeGuide, combining patient reported outcomes with wearable integration. For a rare disease community, the registry is a long term relationship rather than a study visit schedule, and the app is where that relationship lives. Participants report outcomes from their own phones, and wearable data fills in the picture between those reports, which is the kind of participant led programme WeGuide was designed around.

Helping researchers transform ideas into discoveries.

Hear what our clients have to say!

"GenV trusted WeGuide to run a multi-year population health study with roughly 124,000 Victorians, about 50,000 children and 74,000 parents. Longitudinal engagement at this scale requires push notifications, multi-modal data capture, and a whitelabel app that families will keep on their phones for years.""

Susan Clifford

Senior Research Officer

“The main benefit of WeGuide is its convenience. I can’t imagine how we would follow thousands of participants and collect their data without WeGuide!”

Kaya Gardiner

Trial Project Manager

"WeGuide has transformed how we manage our patient registry. The ease of digital screening and obtaining eConsent has significantly improved our workflow."

Emma Weatherley

Managing Director

"The WeGuide trial offers staff a practical tool for recording daily COVID-19 symptoms and temperatures. For those in high-risk areas, daily reminders and alerts provide peace of mind and reassurance about their health."

Kate Cranwell

Manager

"It’s obvious that WeGuide is committed to develop technology that benefits people in the community. WeGuide has been a great partner in achieving this goal within Western Health."

Paul Eleftheriou

Chief Medical Officer

Questions

Straight answers on how WeGuide compares to Jeeva Trials, what switching looks like, and when Jeeva is the right call.

What is Jeeva Trials?

Jeeva Clinical Trials is an eClinical software company based in Manassas, Virginia, founded by Dr. Harsha Rajasimha. Its unified platform combines CTMS, EDC with IWRS, eSource, eCOA/ePRO, eConsent, eVisits, scheduling, recruitment and, since its 2026 acquisition of Clintelligence AI, protocol and site intelligence. It sells to emerging sponsors, CROs and academic medical centres, and is available through AWS Marketplace with usage based contracts.

What are the best Jeeva Trials alternatives?

If you want to replace Jeeva's whole stack, Curebase, OpenClinica and Viedoc are the closest like for like options, with Medable for enterprise pharma programmes. If what you need is a better participant experience, with whitelabel apps, native wearables and long term engagement, WeGuide is the fit, and it can connect to the EDC or CTMS you already run. The right answer depends on whether your bottleneck is operations or participants.

Does WeGuide replace Jeeva's CTMS and EDC?

No. WeGuide isn't a CTMS or an EDC. It's the participant facing layer: eScreening, eConsent, eCOA, engagement, telehealth and wearable data. Teams typically keep their data capture system and connect it through the Integration Engine, which supports two way REDCap sync, HL7 and FHIR, and a REST API with webhooks.

Does Jeeva support wearables?

Jeeva's current product pages for eCOA, engagement and televisits don't describe native wearable integrations, though some older third party descriptions mention wearables. Ask Jeeva directly about your specific devices. WeGuide integrates natively with Garmin, Apple Health, Health Connect and Fitbit Air, and collects raw accelerometer and gyroscope data at 25 Hz on supported Garmin models.

How does pricing compare?

Jeeva publishes a pricing calculator and offers usage based contracts through AWS Marketplace, including a per participant per month dimension. WeGuide is priced per project, quoted on request, with hosting, support and modules included, so the whitelabel app and wearable integrations aren't separate line items. If budget predictability before the first call matters most to you, Jeeva's calculator is a genuine advantage. If you'd rather agree a fixed scope once, our project model is built for that.

How long does it take to move to WeGuide?

Configuration alongside your team typically takes two to four weeks after a discovery call. For a study already running on Jeeva, we'd plan the participant transition and any data export with you before setting a date, and for many teams the cleaner path is to start new registries, cohorts or follow up programmes on WeGuide.

More comparisons